WHO ICTRP trial

Indocyanine green to assess vascularity of ileal conduit anastomosis and…

CTIS2024-518783-13-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2024-518783-13-00
Public title Indocyanine green to assess vascularity of ileal conduit anastomosis and regulate ureteral resection margins during pelvic exenteration for recurrent/persistent gynecological cancer. A pilot study
Scientific title Indocyanine green to assess vascularity of ileal conduit anastomosis and regulate ureteral resection margins during pelvic exenteration for recurrent/persistent gynecological cancer. A pilot study - GREEN-EX
Primary sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries Italy
Conditions Patients with gynecological cancers undergoing pelvic exenteration;Therapeutic area: Diseases [C] - Neoplasms [C04]
Interventions Product Name: INDOCYANINE GREEN, Product Code:SUB14208MIG, Pharmaceutical Form: INJECTION, Other descriptive name: , Strength:
Registration date Sep 10, 2024
Target size 40
Secondary IDs 2022-002536-32
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations